Results 101 to 110 of about 1,039,582 (299)

Oropharyngeal cancer: an emergent disease?

open access: yesSalud Pública de México, 2016
Oropharyngeal cancer incidence has recently increased, thereby attracting public attention. Akin to other malignancies of the upper aerodigestive tract, it has been attributed to the carcinogenic effects of tobacco and alcohol use.
Martín Granados-García
doaj  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Ocorrência de neoplasias em caninos na cidade de Salvador, Bahia (Achados de biopsias).

open access: yesRevista Brasileira de Saúde e Produção Animal, 2005
RESUMO: Estudaram-se microscopicamente 138 amostras obtidas de biopsias de diversos tecidos e órgãos de caninos da região metropolitana de Salvador, Bahia.
V. T. F. de Souza   +2 more
doaj  

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Cistoadenoma seroso del ovario. A propósito de dos casos

open access: yesMedimay, 2007
Se realiza la presentación de dos pacientes, operadas en nuestro servicio con el diagnóstico inicial de tumor ginecológico, cuya sintomatología era bastante vaga e indefinida. Nos llamó la atención, no tanto el diagnóstico final de la entidad, como sí la
Jorge López Martín   +3 more
doaj  

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Hemorragia digestiva por neurofibroma de delgado

open access: yesCirugía del Uruguay, 1980
Lo-s autores presentan un caso de hemorragia digestiva por neurofibroma de delgado en una paciente portadora de una Enfermedad de von Recklinhaufen, en la cua,I se realizó laparotomía con resección de los neurofibromas con el auxilio de la fibrosco-pía ...
Raúl Medina   +5 more
doaj  

Identification and validation of tumor microenvironment-related prognostic biomarkers in breast cancer [PDF]

open access: diamond, 2021
Shanliang Zhong   +5 more
openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy